Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

Tang L.; Parker A.; Flores Y.; Dellario M.; Dickson C.; Amoroso A.; Kottilil S.; Wilson E.

首页> 外文期刊>Journal of viral hepatitis. >Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

【24h】

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

机译：用8周的乙型肝炎患者治疗乙型肝炎：在主要的黑人男性患者人口中非常有效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2018年第2期|共4页
作者
Tang L.; Parker A.; Flores Y.; Dellario M.; Dickson C.; Amoroso A.; Kottilil S.; Wilson E.;
展开▼
作者单位

Univ Maryland Sch Med Inst Human Virol Div Clin Care &

Res Baltimore MD 21201 USA;

VA Maryland Hlth Care Syst Dept Pharm Baltimore MD USA;

VA Maryland Hlth Care Syst Dept Nursing Baltimore MD USA;

VA Maryland Hlth Care Syst Dept Nursing Baltimore MD USA;

VA Maryland Hlth Care Syst Dept Pharm Baltimore MD USA;

Univ Maryland Sch Med Inst Human Virol Div Clin Care &

Res Baltimore MD 21201 USA;

Univ Maryland Sch Med Inst Human Virol Div Clin Care &

Res Baltimore MD 21201 USA;

Univ Maryland Sch Med Inst Human Virol Div Clin Care &

Res Baltimore MD 21201 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population [J] . Tang L., Parker A., Flores Y., Journal of viral hepatitis. . 2018,第2期

机译：用8周的乙型肝炎患者治疗乙型肝炎：在主要的黑人男性患者人口中非常有效
2. Eight weeks treatment duration with Ledipasvir/Sofosbuvir (LDV/SOF) is effective for appropriately selected patients with genotype 1 Hepatitis C virus (HCV) infection: an analysis of multiple real world cohorts totaling > 6,500 patients [J] . Sundaram Vinay, Jeon Christie, Qureshi Kamran, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第6期

机译：Ledipasvir / Sofosbuvir（LDV / SOF）的八周治疗时间对经适当选择的基因型1型丙型肝炎病毒（HCV）感染的患者有效：对超过6,500名患者的多个真实队列进行分析
3. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients [J] . Marcus Julia L., Hurley Leo B., Chamberland Scott, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2018,第6期

机译：莱普斯韦尔和Sofosbuvir在黑人患者中治疗丙型肝炎的8 vs的有效性没有差异
4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015

机译：HLA-C基因在丙型肝炎病毒中感染埃及患者，估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
5. Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States. [D] . Vutien, Philip. 2016

机译：慢性丙型肝炎的治疗率存在种族差异：在美国以人群为基础的队列研究，共73665名患者。
6. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients [O] . Julia L. Marcus, Leo B. Hurley, Scott Chamberland, -1

机译：Ledipasvir和Sofosbuvir治疗黑人黑人丙型肝炎的8周和12周疗效无差异
7. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients [O] . Julia L. Marcus, Leo B. Hurley, Scott Chamberland, 2018

机译：莱普斯韦尔和Sofosbuvir在黑人患者中治疗丙型肝炎的8 vs的有效性没有差异

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

著录项

相似文献

相关主题

期刊订阅